{"version":"1.0","type":"link","title":"Re: Gerhardt Attard, Neeraj Agarwal, Julie Graff, et al. Niraparib plus Abiraterone Acetate and Prednisone for HRR-mutated Metastatic Castration-sensitive Prostate Cancer: Results from the AMPLITUDE Phase 3 Trial. J Clin Oncol 2025;43(17 Suppl):LBA5006.","author_name":"Di Lorenzo G 외","author_url":"https://prs-insight.online/author/Di%20Lorenzo%20G","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/137377","thumbnail_width":1200,"thumbnail_height":630}